Hydrogen Research Study
← Back to Research Library
Human clinical evidenceUncontrolled human studyOther or not reported

[Immunological Effect of Hydrogen Gas-Hydrogen Gas Improves Clinical Outcomes of Cancer Patients].

Akagi J · Gan to kagaku ryoho. Cancer & chemotherapy · 2018

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Cancer and Supportive Oncology Research
Evidence type Human clinical evidence
Publication type Uncontrolled human study
Hydrogen method Other or not reported
molecular hydrogen cancer supportive study 2018 akagi research summary

The publication “[Immunological Effect of Hydrogen Gas-Hydrogen Gas Improves Clinical Outcomes of Cancer Patients].” is organized in H2HUBB under the research focus molecular hydrogen cancer supportive study 2018 akagi. The publication is cited as Akagi J, Gan to kagaku ryoho. Cancer & chemotherapy, 2018. This uncontrolled human study examined [Immunological Effect of Hydrogen Gas-Hydrogen Gas Improves Clinical Outcomes of Cancer Patients]. The abstract describes Human participants. The abstract reports: We found that the proportion of terminal PD-1+ CD8+ T cells was an independent factor for poor prognosis. This is an automated editorial draft based on the abstract and requires source review before publication.

Molecular hydrogen cancer supportive study 2018 akagi overview

In the present study, we investigated whether hydrogen gas influences the proportion of PD-1+ CD8+ T cells in the peripheral blood of 55 Stage… Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.

Study design and hydrogen intervention

Publication type: Uncontrolled human study. Evidence type: Human clinical evidence. Research model or population: Human participants. Blinding: Unknown. Control status: Unknown.

Delivery method: Other or not reported.

Reported findings and scientific interpretation

For this molecular hydrogen cancer supportive study 2018 akagi, the study record reports the following: The abstract reports: We found that the proportion of terminal PD-1+ CD8+ T cells was an independent factor for poor prognosis.

These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.

How this research record was prepared

H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.

Limitations, safety, and original source

Limitations: The abstract alone may not report all methodological limitations; full-text review is required.

Safety: The abstract did not provide detailed safety or adverse-event information.

This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.